TARA
NASDAQ
US
Protara Therapeutics, Inc. - Common Stock
$5.11
▲ +$0.07
(+1.39%)
Vol 512K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$275.2M
ROE
-35.1%
D/E
0.00
Beta
1.35
52W
$3–$8
Wall Street Consensus
14 analysts · Apr 20263
Strong Buy
10
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating
Price Chart
Similar Stocks
OVID
Ovid Therapeutics Inc
$116.1M
FHTX
Foghorn Therapeutics Inc
$305.4M
ORGO
Organogenesis Holdings Inc
P/E 654.1
$657.4M
NBP
NovaBridge Biosciences
$458.9M
AVXL
Anavex Life Sciences Corp
$318.1M
CCCC
C4 Therapeutics Inc
$185.1M
ABEO
Abeona Therapeutics Inc
P/E 3.5
$285.6M
ALEC
Alector Inc
$170.3M
EDIT
Editas Medicine Inc
$200.1M
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.33 | $-0.37 | $-0.04 |
| Sep 2025 | $-0.39 | $-0.31 | +$0.08 |
| Jun 2025 | $-0.41 | $-0.35 | +$0.06 |
| Mar 2025 | $-0.46 | $-0.29 | +$0.17 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -36.7% | -37.0% | -36.7% | -36.7% | -35.1% | -35.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 12.82 | 12.81 | 12.82 | 12.82 | 13.69 | 13.69 |
Key Ratios
ROA (TTM)
-32.5%
P/B
1.1
EPS (TTM)
$-1.43
CF/Share
$-6.09
52W High
$7.82
52W Low
$2.77
$2.77
52-Week Range
$7.82
How does TARA compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
TARA valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.1
▼
56%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
TARA profitability vs Biotechnology peers
ROE
-35.1%
▲
48%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-32.5%
▲
30%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
TARA financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
13.7
▲
208%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.4
▲
39%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
TARA fundamentals radar
TARA
Peer median
Industry
TARA profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
TARA vs peers: key metrics
Latest News
No related news yet